Paper39701285
Management Aspects of Medical Therapy in Graves Disease.
Shah R and 2 others. Endocr Pract, 2025. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Management Aspects of Medical Therapy in Graves Disease. Papers, record 39701285. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39701285
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Graves Disease | Major topic |
| Antithyroid Agents | Major topic |
| Humans | |
| Pregnancy | |
| Female | |
| Iodine Radioisotopes | |
| Pregnancy Complications |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K08 DK142012 | NIDDK NIH HHS | United States | K08DK142012 | PubMed | NIH RePORTER |
| K12 DK133995 | NIDDK NIH HHS | United States | K12DK133995 | PubMed and NIH | NIH RePORTER |
References99
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18946064 | Alemtuzumab vs. interferon beta-1a in early multiple sclerosis. | N Engl J Med | 2008 | https://conductscience.org/library/papers/18946064 | PubMed |
| 2 | 34760672 | Rapid Differential Diagnosis of Thyrotoxicosis Using T3/T4 Ratio, FT3/FT4 Ratio and Color Doppler of Thyroid Gland. | Indian J Endocrinol Metab | 2021 | https://conductscience.org/library/papers/34760672 | PubMed |
| 3 | 19445623 | Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily. | Thyroid | 2009 | https://conductscience.org/library/papers/19445623 | PubMed |
| 4 | 35662442 | 2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease. | Endocrinol Metab Clin North Am | 2022 | https://conductscience.org/library/papers/35662442 | PubMed |
| 5 | 21044113 | Subclinical thyrotoxicosis in an outpatient population - predictors of outcome. | Clin Endocrinol (Oxf) | 2011 | https://conductscience.org/library/papers/21044113 | PubMed |
| 6 | 36706788 | Comparison Between Thyroid Stimulating Immunoglobulin and TSH-Receptor Antibodies in the Management of Graves' Orbitopathy. | Exp Clin Endocrinol Diabetes | 2023 | https://conductscience.org/library/papers/36706788 | PubMed |
| 7 | 16571093 | Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period. | Thyroid | 2006 | https://conductscience.org/library/papers/16571093 | PubMed |
| 8 | 30283735 | 2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism. | Eur Thyroid J | 2018 | https://conductscience.org/library/papers/30283735 | PubMed |
| 9 | 1691908 | Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy. | Arch Intern Med | 1990 | https://conductscience.org/library/papers/1691908 | PubMed |
| 10 | 32107168 | Graves' disease: Epidemiology, genetic and environmental risk factors and viruses. | Best Pract Res Clin Endocrinol Metab | 2020 | https://conductscience.org/library/papers/32107168 | PubMed |
| 11 | 12794168 | Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway. | J Immunol | 2003 | https://conductscience.org/library/papers/12794168 | PubMed |
| 12 | 31772785 | A Case Report of Graves' Disease Induced by the Anti-Human Programmed Cell Death-1 Monoclonal Antibody Pembrolizumab in a Bladder Cancer Patient. | Case Rep Endocrinol | 2019 | https://conductscience.org/library/papers/31772785 | PubMed |
| 13 | 25149085 | Thymic hyperplasia in patients with Graves' disease. | J Endocrinol Invest | 2014 | https://conductscience.org/library/papers/25149085 | PubMed |
| 14 | 12915620 | Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies. | J Clin Endocrinol Metab | 2003 | https://conductscience.org/library/papers/12915620 | PubMed |
| 15 | 32811342 | Treatment of Subclinical Hyperthyroidism in the Elderly: Comparison of Radioiodine and Long-Term Methimazole Treatment. | Thyroid | 2021 | https://conductscience.org/library/papers/32811342 | PubMed |
| 16 | 6467634 | Maternal hyperthyroidism and congenital malformation in the offspring. | Clin Endocrinol (Oxf) | 1984 | https://conductscience.org/library/papers/6467634 | PubMed |
| 17 | 21591944 | Selenium and the course of mild Graves' orbitopathy. | N Engl J Med | 2011 | https://conductscience.org/library/papers/21591944 | PubMed |
| 18 | 30320502 | ANNIVERSARY REVIEW: Antithyroid drug therapy: 70 years later | Eur J Endocrinol | 2018 | https://conductscience.org/library/papers/30320502 | PubMed |
| 19 | 28467880 | Teprotumumab for Thyroid-Associated Ophthalmopathy. | N Engl J Med | 2017 | https://conductscience.org/library/papers/28467880 | PubMed |
| 20 | 29771756 | Thyrotropin Receptor Antibodies-An Overview. | Ophthalmic Plast Reconstr Surg | 2018 | https://conductscience.org/library/papers/29771756 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42894817 | Genetic polymorphisms and early responses predict refractory hyperthyroidism during antithyroid drug therapy. | iScience | 2026 | https://conductscience.org/library/papers/42894817 | PubMed |
| 42775368 | Refractory Graves' Disease With Propylthiouracil-Induced Hemophagocytic Lymphohistiocytosis and Multiple Drug Allergies Treated With Total Thyroidectomy: A Case Report. | Cureus | 2026 | https://conductscience.org/library/papers/42775368 | PubMed |
| 42661926 | Cytokines and drugs targeting cytokines in Graves' disease and thyroid eye disease. | Front Immunol | 2026 | https://conductscience.org/library/papers/42661926 | PubMed |
| 41917239 | Aescin and rutin mitigate hyperthyroidism-induced multisystem dysfunction via antioxidant and anti-inflammatory mechanisms in a rat model. | Sci Rep | 2026 | https://conductscience.org/library/papers/41917239 | PubMed |
| 41894843 | Severe agranulocytosis in patient with Graves' disease on second exposure to carbimazole. | Endocrinol Diabetes Metab Case Rep | 2026 | https://conductscience.org/library/papers/41894843 | PubMed |
| 41657797 | Analysis of the impact of Graves' disease on the efficacy of initial radioactive iodine therapy in patients with differentiated thyroid cancer. | Am J Cancer Res | 2026 | https://conductscience.org/library/papers/41657797 | PubMed |
| 41373736 | Special Issue "Molecular Biology of the Thyroid Cancer and Thyroid Dysfunctions". | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373736 | PubMed |
| 41021009 | Association between maternal thyroid dysfunction and neurodevelopmental disorders in offspring: a population-based cohort study. | Eur Child Adolesc Psychiatry | 2026 | https://conductscience.org/library/papers/41021009 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39701285
GET https://conductscience.org/api/papers/v1/39701285/references?page=2